FLT3 and acute myeloid leukemia: Experiments have shown that when PAMAM dendrimers are combined with FLT3 ligands and loaded with miR-150, selective clearance of FLT3-overexpressing acute myeloid leukemia (AML) cells can be achieved, and extremely low side effects are shown in vivo (187).